Luca Issi
Stock Analyst at RBC Capital
(3.91)
# 645
Out of 5,090 analysts
219
Total ratings
50.76%
Success rate
9.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Luca Issi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRNA Moderna | Maintains: Sector Perform | $28 → $25 | $26.86 | -6.92% | 18 | Nov 21, 2025 | |
| AGIO Agios Pharmaceuticals | Downgrades: Sector Perform | $57 → $28 | $27.25 | +2.75% | 1 | Nov 20, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Outperform | $45 → $52 | $61.56 | -15.53% | 10 | Nov 19, 2025 | |
| KRRO Korro Bio | Downgrades: Sector Perform | $85 → $8 | $6.82 | +17.30% | 8 | Nov 13, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Sector Perform | $42 → $50 | $57.55 | -13.12% | 15 | Nov 11, 2025 | |
| RGNX REGENXBIO | Maintains: Outperform | $17 → $19 | $13.05 | +45.59% | 11 | Nov 7, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Sector Perform | $14 → $9 | $9.42 | -4.46% | 7 | Nov 7, 2025 | |
| DYN Dyne Therapeutics | Maintains: Outperform | $23 → $30 | $20.77 | +44.44% | 4 | Nov 6, 2025 | |
| QURE uniQure | Maintains: Outperform | $65 → $45 | $21.11 | +113.17% | 7 | Nov 4, 2025 | |
| ARGX argenx SE | Maintains: Outperform | $850 → $860 | $896.79 | -4.10% | 2 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $82 | $81.45 | +0.68% | 10 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $5 → $7 | $9.40 | -25.49% | 2 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $61 → $72 | $71.71 | +0.40% | 3 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $435 → $500 | $456.88 | +9.44% | 28 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $210 → $230 | $206.59 | +11.33% | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $5 → $4 | $4.22 | -5.17% | 8 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $1.44 | +594.44% | 9 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $21 → $18 | $23.70 | -24.05% | 7 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $20 | $9.21 | +117.16% | 5 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $2 | $0.51 | +295.18% | 6 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $17 | $12.48 | +36.22% | 1 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $11 → $13 | $8.47 | +53.48% | 6 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $35 | $10.99 | +218.37% | 7 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $24 → $26 | $27.52 | -5.51% | 7 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $70 | $53.12 | +31.78% | 12 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $57 | $38.81 | +46.87% | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $5 → $4 | $2.42 | +65.63% | 8 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $77 | $36.87 | +108.84% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $7 → $15 | $7.47 | +100.80% | 5 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $1.87 | +648.66% | 5 | Aug 7, 2024 |
Moderna
Nov 21, 2025
Maintains: Sector Perform
Price Target: $28 → $25
Current: $26.86
Upside: -6.92%
Agios Pharmaceuticals
Nov 20, 2025
Downgrades: Sector Perform
Price Target: $57 → $28
Current: $27.25
Upside: +2.75%
Arrowhead Pharmaceuticals
Nov 19, 2025
Maintains: Outperform
Price Target: $45 → $52
Current: $61.56
Upside: -15.53%
Korro Bio
Nov 13, 2025
Downgrades: Sector Perform
Price Target: $85 → $8
Current: $6.82
Upside: +17.30%
CRISPR Therapeutics AG
Nov 11, 2025
Maintains: Sector Perform
Price Target: $42 → $50
Current: $57.55
Upside: -13.12%
REGENXBIO
Nov 7, 2025
Maintains: Outperform
Price Target: $17 → $19
Current: $13.05
Upside: +45.59%
Intellia Therapeutics
Nov 7, 2025
Maintains: Sector Perform
Price Target: $14 → $9
Current: $9.42
Upside: -4.46%
Dyne Therapeutics
Nov 6, 2025
Maintains: Outperform
Price Target: $23 → $30
Current: $20.77
Upside: +44.44%
uniQure
Nov 4, 2025
Maintains: Outperform
Price Target: $65 → $45
Current: $21.11
Upside: +113.17%
argenx SE
Oct 31, 2025
Maintains: Outperform
Price Target: $850 → $860
Current: $896.79
Upside: -4.10%
Oct 30, 2025
Maintains: Outperform
Price Target: $80 → $82
Current: $81.45
Upside: +0.68%
Oct 30, 2025
Maintains: Sector Perform
Price Target: $5 → $7
Current: $9.40
Upside: -25.49%
Oct 28, 2025
Downgrades: Sector Perform
Price Target: $61 → $72
Current: $71.71
Upside: +0.40%
Sep 19, 2025
Maintains: Outperform
Price Target: $435 → $500
Current: $456.88
Upside: +9.44%
Aug 8, 2025
Maintains: Outperform
Price Target: $210 → $230
Current: $206.59
Upside: +11.33%
May 15, 2025
Maintains: Sector Perform
Price Target: $5 → $4
Current: $4.22
Upside: -5.17%
May 14, 2025
Reiterates: Outperform
Price Target: $10
Current: $1.44
Upside: +594.44%
May 8, 2025
Maintains: Sector Perform
Price Target: $21 → $18
Current: $23.70
Upside: -24.05%
Mar 25, 2025
Maintains: Outperform
Price Target: $24 → $20
Current: $9.21
Upside: +117.16%
Mar 18, 2025
Reiterates: Sector Perform
Price Target: $2
Current: $0.51
Upside: +295.18%
Mar 18, 2025
Initiates: Outperform
Price Target: $17
Current: $12.48
Upside: +36.22%
Mar 17, 2025
Maintains: Outperform
Price Target: $11 → $13
Current: $8.47
Upside: +53.48%
Mar 3, 2025
Maintains: Outperform
Price Target: $39 → $35
Current: $10.99
Upside: +218.37%
Feb 26, 2025
Maintains: Sector Perform
Price Target: $24 → $26
Current: $27.52
Upside: -5.51%
Feb 20, 2025
Reiterates: Sector Perform
Price Target: $70
Current: $53.12
Upside: +31.78%
Jan 21, 2025
Reiterates: Outperform
Price Target: $57
Current: $38.81
Upside: +46.87%
Dec 13, 2024
Maintains: Sector Perform
Price Target: $5 → $4
Current: $2.42
Upside: +65.63%
Nov 6, 2024
Reiterates: Outperform
Price Target: $77
Current: $36.87
Upside: +108.84%
Oct 21, 2024
Maintains: Sector Perform
Price Target: $7 → $15
Current: $7.47
Upside: +100.80%
Aug 7, 2024
Reiterates: Outperform
Price Target: $14
Current: $1.87
Upside: +648.66%